Followers | 603 |
Posts | 71390 |
Boards Moderated | 2 |
Alias Born | 09/27/2006 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 19, 2024 8:32:51 AM
https://www.otcmarkets.com/stock/MGRX/news/story?e&id=2744232
"King of the Internet" Dave Portnoy's Uber-Popular Sports Media Company to Spotlight FDA-Approved Oral Testosterone Replacement ‘Prime’ by MangoRx, Powered by Kyzatrex®
Dallas, Texas, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product (“GROW”) and erectile dysfunction (“ED”) drug (“Mango”), is excited to announce that it will be a Marquee Sponsor for Barstool Sports’ week-long programming schedule surrounding the Big Game in Las Vegas on Sunday, Feb 11, 2024.
The MangoRx brand will be featured across Barstool programming during the week of the Super Bowl, including The Dozen Trivia Live Show Pro-Am with Dave Portnoy and other Barstool fan favorites, Stool Scenes' "Super Bowl Special", and The Rundown, in addition to sponsoring the Big Game’s Day-of livestream from Chicago HQ, the brand’s content house in Las Vegas, and several other podcasts and radio shows.
In addition, as a Marquee Sponsor, MangoRx will be prominently featured on the Barstool Podcasts starting the week of January 22nd and running through March 15th with an estimated number of over 7 million views and impressions.
Dave Portnoy, one of the most recognizable faces in the American sports media industry, founded Barstool Sports, growing the brand into the multi-million-dollar preeminent digital sports media presence. Portnoy, famously known as “El Presidente”, aka “The Mogul”, aka “Davey Pageviews” and the “King of Pizza Reviews”, has established an unassailable empire of influence through Barstool Sports' deeply authentic voice. Already the #1 most followed publisher in the 18-34 demographic and a top-ten global podcast publisher and set to become the first brand to achieve 7 billion likes on TikTok, the fastest growing social media platform worldwide, Barstool Sports, through its innovative content, has established a massive distribution footprint on multiple platforms.
"The Barstool livestream for the Big Game saw its audience grow by nearly 200% year-over-year from 2022 to 2023," remarked Jacob Cohen, CEO and Co-Founder of MangoRx. “This is dead center in terms of our target market for our major products, and we couldn’t find a bigger megaphone to power our brand reach than Dave’s empire of influence. Barstool is #1 across the board and we are thrilled to align our brand with Dave and his team for the biggest media event of the year!”
As a Marquee sponsor of Barstool’s Big Game live stream, MangoRx’s products and branding will be present throughout their newly opened Chicago HQ including live promotional giveaways to viewers of the stream.
“We’re thrilled to continue and build upon our partnership with MangoRx in what has been a natural fit between both of our brands”, said Ryan McDermott, Head of Sales, Barstool Sports. “The Big Game is the biggest night for advertisers and we’re looking forward to showcase ‘Prime’ to our passionate fans so this product stands out all week long.”
MangoRx will be using this marketing opportunity to feature its newly launched product, 'Prime' by MangoRx, powered by KYZATREX®️, an innovative FDA-approved oral Testosterone Replacement Therapy (TRT) product KYZATREX, a prescription drug that is used to treat adult men who have low or no testosterone levels due to certain medical conditions, is one of only three FDA approved TRT treatments that is delivered orally--as opposed to the traditional, invasive, and inconvenient injection-based drug delivery protocol. KYZATREX delivers testosterone in a softgel capsule that is absorbed primarily via the lymphatic system, avoiding liver toxicity.
KYZATREX is one of the only FDA approved testosterone replacement therapy ("TRT") treatments that is delivered orally—as opposed to the traditional, invasive, and inconvenient injection-based drug delivery protocol. KYZATREX is delivered as a softgel capsule that is absorbed primarily via the lymphatic system, avoiding liver toxicity.
The benefits of ‘Prime,’ powered by KYZATREX, over traditional injectable TRTs include enhanced vitality, improved mood, sharper cognition, optimized physical performance, and balanced hormonal levels at 96% efficacy by day 90, as demonstrated in Phase 3 clinical research by Marius Pharmaceuticals. With ‘Prime,’ MangoRx will expand broad-based consumer access to this revolutionary therapy.
![Bullish](/static/images/ih2-bull.png)
Recent MGRX News
- MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology • GlobeNewswire Inc. • 07/24/2024 12:15:00 PM
- Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access • GlobeNewswire Inc. • 07/18/2024 08:05:00 PM
- MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts • GlobeNewswire Inc. • 07/16/2024 12:20:00 PM
- MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department • GlobeNewswire Inc. • 07/12/2024 05:30:00 PM
- MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets • GlobeNewswire Inc. • 07/11/2024 12:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 06:57:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 05:28:45 PM
- MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:24 PM
- MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies • GlobeNewswire Inc. • 06/04/2024 08:00:00 PM
- MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications • GlobeNewswire Inc. • 05/21/2024 12:30:00 PM
- MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration • GlobeNewswire Inc. • 05/16/2024 08:40:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/16/2024 05:59:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/16/2024 01:19:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:52:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/14/2024 01:00:58 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/06/2024 09:32:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/06/2024 08:43:00 PM
- Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM